152 related articles for article (PubMed ID: 35877247)
1. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER.
Li Z; Ren H; Zhao L; Zhang X; Wang T; Sun C; Niu P; Wang W; Fei H; Guo C; Chen Y; Zhao D
Curr Oncol; 2022 Jul; 29(7):4879-4892. PubMed ID: 35877247
[TBL] [Abstract][Full Text] [Related]
2. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
Xu B; Chu Y; Hu Q; Song Q
Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
[TBL] [Abstract][Full Text] [Related]
3. Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach.
Xie JW; Lu J; Lin JX; Zheng CH; Li P; Wang JB; Chen QY; Cao LL; Lin M; Tu RH; Huang CM
Oncotarget; 2017 Aug; 8(34):57495-57504. PubMed ID: 28915689
[TBL] [Abstract][Full Text] [Related]
4. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
5. De-escalating chemotherapy for stage I-II gastric neuroendocrine carcinoma? A real-world competing risk analysis.
Du D; Xie Y; Li X; Ni Z; Shi J; Huang H
World J Surg Oncol; 2023 May; 21(1):142. PubMed ID: 37149679
[TBL] [Abstract][Full Text] [Related]
6. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
Chen J; Wang A; Ji K; Bu Z; Ji J
BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
[TBL] [Abstract][Full Text] [Related]
7. Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment.
Xie JW; Li P; Wang JB; Lin JX; Lu J; Chen QY; Yang YH; Kang DY; Zheng CH; Huang CM
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2391-2397. PubMed ID: 30209612
[TBL] [Abstract][Full Text] [Related]
8. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
Front Oncol; 2022; 12():930491. PubMed ID: 35912176
[TBL] [Abstract][Full Text] [Related]
9. Exploration of gastric neuroendocrine carcinoma (GNEC) specific signaling pathways involved in chemoresistance via transcriptome and
Xie J; Chen P; Xie H; Sun Y; Huang Z; Wei R; Miao Z; Wang Q; Zhang SD; Wong KH; Lin Y; Huang C; Kwok HF
Comput Struct Biotechnol J; 2020; 18():2610-2620. PubMed ID: 33033581
[TBL] [Abstract][Full Text] [Related]
10. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.
Hu P; Bai J; Liu M; Xue J; Chen T; Li R; Kuai X; Zhao H; Li X; Tian Y; Sun W; Xiong Y; Tang Q
Gastric Cancer; 2020 Jul; 23(4):591-599. PubMed ID: 32026156
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2.
Chen S; Sun L; Chen H; Li J; Lu C; Yang Y; Sun Y
Histopathology; 2023 Nov; 83(5):700-711. PubMed ID: 37403531
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
[TBL] [Abstract][Full Text] [Related]
13. The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis.
Cao L; Wu HF; Zhao L; Bai Y; Jiang ZL; Yang WJ; Liu SX
J Radiat Res; 2020 Jul; 61(4):594-601. PubMed ID: 32567658
[TBL] [Abstract][Full Text] [Related]
14. The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysis.
Xie Y; Du D; Song X; Li X; Ni Z; Huang H
World J Surg Oncol; 2022 Apr; 20(1):123. PubMed ID: 35430809
[TBL] [Abstract][Full Text] [Related]
15. Marital status, an independent predictor for survival of gastric neuroendocrine neoplasm patients: a SEER database analysis.
Zhou YJ; Lu XF; Zheng KI; Wang QW; Chen JN; Zhang QW; Yan FR; Li XB
BMC Endocr Disord; 2020 Jul; 20(1):111. PubMed ID: 32703291
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
17. Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study.
Xie Y; Song X; Dong W; Jin H; Ni Z; Li X; Huang H
Biomed Res Int; 2022; 2022():1565207. PubMed ID: 35141330
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognostic factors of elderly small intestine adenocarcinoma using propensity score matching analysis: a study based on SEER database.
Liu QY; Xie L; Yang XY; Yang L; Lei XL
Int J Colorectal Dis; 2022 Nov; 37(11):2397-2407. PubMed ID: 36301375
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis.
Zi M; Ma Y; Chen J; Pang C; Li X; Yuan L; Liu Z; Yu P
Cancer Med; 2024 Feb; 13(4):e7011. PubMed ID: 38457192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]